蛋白名稱(chēng):FGF2人重組蛋白，10014-HNAE
蛋白構(gòu)建:A DNA sequence encoding the mature form of human bFGF (NP_001997.5) (Pro143-Ser288) was expressed with an additional Met at the N-terminus.
表達(dá)宿主:E. coli
蛋白純度:≥ 95 % as determined by SDS-PAGE
蛋白活性:

1.iPSC-derived human vascular organoids (Day 7) were cultured with FGF2 (Cat#10014-HNAE), VEGFA (Cat# 11066-HNAH), EGF (Cat#10605-HNAE). Red arrows represent vascular organoids. Image taken at 10x magnification.(Routinely tested) 

2.Measured in a cell proliferation assay using Balb/c 3T3 mouse embryonic fibroblasts. The ED50 for this effect is typically 0.01-0.1 ng/mL. 

3.Human lung cancer organoids were cultured with FGF2(Cat#10014-HNAE), FGF4(Cat#16043-HNAE), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology. 

4.Human lung organoids were cultured with FGF2(Cat#10014-HNAE), FGF4(Cat#16043-HNAE), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology. 

5.Human cholangiocarcinomas organoids were cultured with FGF2(Cat#10014-HNAE), HGF(Cat#10463-HNAS), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology. 

6.Human liver cancer organoids were cultured with FGF2(Cat#10014-HNAE), HGF(Cat#10463-HNAS), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), TGFB1(Cat#10804-HNAC), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology. 

7.Human kidney cancer organoids were cultured with FGF2(Cat#10014-HNAE), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

蛋白內(nèi)毒素:< 10 EU per mg protein.
預(yù)測(cè)N端:Met
蛋白分子量:The recombinant human bFGF consists of 147 amino acids and predicts a molecular mass of 16.5 kDa.
蛋白NP號(hào):NP_001997.5
蛋白氨基酸序列:Pro143-Ser288
蛋白標(biāo)簽:Native

歡迎去義翹神州網(wǎng)查看FGF2人重組蛋白詳細(xì)信息。

義翹神州業(yè)務(wù)布局

義翹神州總部位于中國(guó)北京，在上海、廣州設(shè)立了分公司，于美國(guó)、歐洲、日本、中國(guó)蘇州、中國(guó)泰州建立了子公司，并在擁有幾十家經(jīng)銷(xiāo)商，致力于為客戶(hù)提供更加便捷、高效、優(yōu)質(zhì)、專(zhuān)業(yè)的服務(wù)。

我們的宗旨：

堅(jiān)持自主開(kāi)發(fā)，不斷提升技術(shù)水平，為生命科學(xué)研究和生物醫(yī)藥創(chuàng)新研發(fā)提供高質(zhì)量試劑和服務(wù)支撐，助力推動(dòng)健康事業(yè)發(fā)展，造福人類(lèi)。

人才建設(shè)：

①人才隊(duì)伍：900+

②碩士及以上學(xué)歷人才：230+

我們的客戶(hù)

客戶(hù)涵蓋大學(xué)、科研院所、醫(yī)藥研發(fā)企業(yè)等國(guó)內(nèi)外各類(lèi)生物研發(fā)單位

硬件設(shè)施

①超過(guò)20,000平米的研發(fā)生產(chǎn)中心

②超過(guò)5,000平米的潔凈生產(chǎn)車(chē)間